95 related articles for article (PubMed ID: 2969877)
1. Chronic graft-vs.-host disease: changes in natural suppressor cells and mast cells.
Claman HN; Holda JH; Maier T; Choi KL
Isr J Med Sci; 1988 Jul; 24(7):367-9, 371. PubMed ID: 2969877
[No Abstract] [Full Text] [Related]
2. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
Choi KL; Claman HN
Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
[No Abstract] [Full Text] [Related]
3. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.
Cohen JL; Boyer O
Curr Opin Immunol; 2006 Oct; 18(5):580-5. PubMed ID: 16879951
[TBL] [Abstract][Full Text] [Related]
4. Suppressor mechanisms active in the control of graft-v-host disease.
Tutschka PJ
Transplant Proc; 1987 Dec; 19(6 Suppl 7):69-74. PubMed ID: 2962355
[No Abstract] [Full Text] [Related]
5. Mast cells and fibrosis. The relevance to scleroderma.
Claman HN
Rheum Dis Clin North Am; 1990 Feb; 16(1):141-51. PubMed ID: 2406804
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease: how can we release Prometheus?
Teshima T; Wynn TA; Soiffer RJ; Matsuoka K; Martin PJ
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):142-50. PubMed ID: 18162235
[No Abstract] [Full Text] [Related]
7. Natural suppressor cells.
Maier T; Holda JH; Claman HN
Prog Clin Biol Res; 1989; 288():235-44. PubMed ID: 2524070
[No Abstract] [Full Text] [Related]
8. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
Claman HN; Choi KL; Sujansky W; Vatter AE
J Immunol; 1986 Sep; 137(6):2009-13. PubMed ID: 3745920
[TBL] [Abstract][Full Text] [Related]
9. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
Pals ST; Radaszkiewicz T; Gleichmann E
J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
11. The host response in graft versus host disease. III. The in vitro induction of regulatory cells in chronic murine graft versus host disease.
Mann RA; Singh AB; Jetzt AE; Singh M
Cell Immunol; 1995 Aug; 164(1):1-10. PubMed ID: 7634339
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Bladon J; Taylor P
Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
[TBL] [Abstract][Full Text] [Related]
13. Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity?
Martinic MM; von Herrath MG
Eur J Immunol; 2006 Sep; 36(9):2299-303. PubMed ID: 16952145
[TBL] [Abstract][Full Text] [Related]
14. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
15. Regulatory (suppressor) T cells in peripheral allograft tolerance and graft-versus-host reaction.
Rifle G; Hervé P
Transplantation; 2004 Jan; 77(1 Suppl):S5. PubMed ID: 14726759
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
17. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
18. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Rappaport H
Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells.
Sakaguchi S
Springer Semin Immunopathol; 2006 Aug; 28(1):1-2. PubMed ID: 16896608
[No Abstract] [Full Text] [Related]
20. [Graft vs host disease].
Moalic V; Ferec C
Pathol Biol (Paris); 2006 May; 54(5):304-8. PubMed ID: 16530350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
